Cranswick plc (LON:CWK) will increase its dividend from last year's comparable payment on the 30th of August to £0.673. This makes the dividend yield about the same as the industry average at 2.0%. View our latest analysis for Cranswick Cranswick's Payment Has Solid Earnings …
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. To keep the lesson grounded in practicality, we'll use ROE to better …
LUXEMBOURG, July 03, 2024--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Expanding on its original press release of 25 June 2024 in response to the report by Muddy Waters, LLC (MW) on Eurofins published on 24 June 2024, Eurofins is providing detailed information to refute the most …
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in the case of St. James's Place plc (LON:STJ), it sends a favourable message to the company's shareholders. Although we don't think shareholders …
Amid a backdrop of fluctuating European markets and rising bond yields, investors are increasingly seeking stable returns, making high-yield dividend stocks from Euronext Amsterdam particularly attractive. These stocks offer a compelling combination of yield and potential resilience against the broader market's volatility. Top 5 …
Amidst a landscape of fluctuating European markets, with particular attention on upcoming elections and economic indicators influencing bond yields, the Netherlands continues to present intriguing investment opportunities. In such an environment, growth companies with high insider ownership stand out as potentially resilient choices due …
Regeneron Pharmaceuticals, Inc. First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved lung function and also improved health-related quality of life Dupixent is the first new treatment …
Sanofi - Aventis Groupe Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD First-in-world approval of Dupixent for adults with uncontrolled COPD with raised blood eosinophils based on two landmark phase 3 studies showing Dupixent significantly reduced exacerbations, improved …
AMSTERDAM, July 03, 2024--(BUSINESS WIRE)--Regulatory News: CTP N.V. (‘CTP’ or the ‘Company’), Europe’s largest listed owner, developer and manager of logistics and industrial real estate by gross lettable area, will announce its H1-2024 results on Thursday, 8 August 2024. On the day, at 09.00 …
We recently compiled a list of Billionaire Phillipe Laffont’s Top 10 “Mostly AI” Stock Picks. In this article, we are going to take a look at where Vertiv Holdings Co (NYSE:VRT) stands against Philippe Laffont's other stock picks. Billionaire Philippe Laffont is a Founder …